Otsuka Holdings Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Otsuka Holdings Company Limited with three other
companies in this sector in Japan:
Astellas Pharma Incorporated
sales of 1.31 trillion Japanese Yen [US$12.26 billion]
of which 58%
Daiichi Sankyo Company Limited
(955.12 billion Japanese Yen [US$8.93 billion]
of which 93%
was prescription drugs), and
Takeda Pharmaceutical Company Limited
(1.73 trillion Japanese Yen [US$16.19 billion]
of which 91%
was Pharmaceutical Business).
During the year ended December of 2017, sales at
Otsuka Holdings Company Limited were ¥1.24 trillion (US$11.59 billion).
increase of 3.7%
versus 2016, when the company's sales were ¥1.20 trillion.
Despite this increase, sales are still
below the level achieved in 2015, when Otsuka Holdings Company Limited
reported sales of ¥1.45 trillion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Otsuka Holdings Company Limited had sales
of ¥1.15 trillion.
Sales of Other Businesses saw an increase
that was more than double the company's growth rate: sales were up
8.2% in 2017, from
¥106.51 billion to ¥115.20 billion.